Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The combination of sarcopenia and obesity (i.e., sarcopenic obesity) is more strongly associated with disability and metabolic/cardiovascular diseases than obesity or sarcopenia alone. Therefore, countermeasures that simultaneously suppress fat gain and muscle atrophy to prevent an increase in sarcopenic obesity are warranted. The aim of this study was to investigate the simultaneous effects of fucoxanthinol (FXOH) on fat loss in mature adipocytes and the inhibition of atrophy and loss in myotubes induced by oxidative stress. C2C12 myotubes were treated with FXOH for 24 h and further incubated with hydrogen peroxide (H 2 O 2) for 24 h. The area of myosin heavy chain-positive myotubes and the ROS concentration were measured. Mature 3T3-L1 adipocytes were treated with FXOH for 72 h. The triacylglycerol (TG) content and glycerol and fatty acid (FA) release were biochemically measured. The myotube area was smaller in H 2 O 2-treated cells than that in control cells. However, FXOH protected against the H 2 O 2-induced decreases in myotube area. Further, the ROS concentration was significantly higher in the FXOH-treated cells compared with that in the control cells, although it was significantly lower than that in the H 2 O 2-treated cells. On the other hand, in the mature adipocytes, the TG content was significantly decreased by FXOH treatment compared to that in the control. Moreover, FXOH treatment significantly increased glycerol and FA release compared with that of the control. These results suggest that FXOH inhibits H 2 O 2-induced atrophy and loss in myotubes and activates lipolysis and decreases the TG content in mature adipocytes. Accordingly, FXOH has the potential to exert anti-sarcopenic obesity effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fucoxanthinol (FXOH) (a metabolite of fucoxanthin (FX) that has antiobesity effects and that accumulates in white adipocytes of mice) showed antisarcopenic and antiobesity activities in vitro, mainly by decreasing muscle atrophy, incrementing lipolysis, and decreasing triglyceride (TG) content. Interestingly, the effects of FXOH were dependent on Os [136].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [136]
Citations
Cites
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Achieving the Balance between ROS and Antioxidants: When to Use the Synthetic Antioxidants
Poljsak, B., Šuput, D., & Milisav, I. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/956792 · Cited by 1,301
AMPK and PPARδ Agonists Are Exercise Mimetics
Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y.-X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.051 · Cited by 1,222
Sarcopenic obesity: A new category of obesity in the elderly
Zamboni, M., Mazzali, G., Fantin, F., Rossi, A., & Di Francesco, V. (2008) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.10.002 · Cited by 953
Morley, J. E., Baumgartner, R. N., Roubenoff, R., Mayer, J., & Nair, K. S. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.113504 · Cited by 936
Wilkinson, D. J., Piasecki, M., & Atherton, P. J. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.07.005 · Cited by 874
Fatty acid metabolism: Target for metabolic syndrome
Wakil, S. J., & Abu-Elheiga, L. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800079-jlr200 · Cited by 731
Oxidative Stress, Molecular Inflammation and Sarcopenia
Meng, S.-J., & Yu, L.-J. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11041509 · Cited by 637 · cited 2×
“A reduction in oxidative stress suppresses the expression and activation of muscle atrophy-related protein, thereby attenuating sarcopenia [16].”
BackgroundHypoxia-induced energy stress regulates mRNA translation and cell growth
Liu, L., Cash, T. P., Jones, R. G., Keith, B., Thompson, C. B., & Simon, M. C. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.01.010 · Cited by 607
Cited by
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
Han, Y., Kim, D. H., & Pack, S. P. (2024) · Marine Drugs · doi:10.3390/md22110496 · Cited by 43
Yang, X., Ge, X.-C., Jiang, S.-Y., & Yang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000739 · Cited by 37
Effects of Fucoxanthin on the Inhibition of Dexamethasone-Induced Skeletal Muscle Loss in Mice
Yoshikawa, M., Hosokawa, M., Miyashita, K., Nishino, H., & Hashimoto, T. (2021) · Nutrients · doi:10.3390/nu13041079 · Cited by 25
Self-citationRole of carotenoids in adipose tissue through the AMPK-mediated pathway
Ferreira, Y. A. M., Jamar, G., Estadella, D., & Pisani, L. P. (2023) · Food & Function · doi:10.1039/d2fo03781e · Cited by 18
Metadata
- Authors
- Yoshikawa, M., Hosokawa, M., Miyashita, K., Fujita, T., Nishino, H., & Hashimoto, T.
- Affiliations
- Ritsumeikan University (JP)
- Hokkaido University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Corresponding author
- Hashimoto, Takeshi
- Venue
- Molecular Biology Reports
- Published
- 2020-03-16
- Volume
- 47
- Issue
- 4
- Pages
- 2703-2711
- ISSN
- 0301-4851 (ISSN-L)
- 1573-4978
- OpenAlex
- W3010870284
- Cited by
- 15
- References
- 43
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 1
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Biology Reports (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japanese Ministry of Education, Culture, Sports, Science, and Technology (26702029, 18K19762)
- TOYO INSTITUTE of FOOD TECHNOLOGY
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- fucoxanthinol, sarcopenic obesity, muscle atrophy, oxidative stress, hydrogen peroxide, myotubes, adipocytes, triglycerides, lipolysis, reactive oxygen species, myosin heavy chain, fat loss
- MeSH terms
- Animals, Atrophy, Cell Line, Fatty Acids, Hydrogen Peroxide, Lipolysis, Metabolic Diseases, Muscular Atrophy, Obesity, Triglycerides, Adipocytes, Oxidative Stress, Muscle Fibers, Skeletal, beta Carotene, 3T3-L1 Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes. https://app.cochat.ai/papers/10.1007/s11033-020-05369-8
- The paper
- Yoshikawa, M., Hosokawa, M., Miyashita, K., Fujita, T., Nishino, H., & Hashimoto, T. (2020). Fucoxanthinol attenuates oxidative stress-induced atrophy and loss in myotubes and reduces the triacylglycerol content in mature adipocytes. Molecular Biology Reports. https://doi.org/10.1007/s11033-020-05369-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.